- Home
- IVR vs MRVI Comparison
IVR vs MRVI Comparison
Compare IVR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVR
- MRVI
- Stock Information
- Founded
- IVR 2008
- MRVI 2014
- Country
- IVR United States
- MRVI United States
- Employees
- IVR N/A
- MRVI 560
- Industry
- IVR Real Estate Investment Trusts
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- IVR Real Estate
- MRVI Health Care
- Exchange
- IVR Nasdaq
- MRVI Nasdaq
- Market Cap
- IVR 494.7M
- MRVI 449.6M
- IPO Year
- IVR 2009
- MRVI 2020
- Fundamental
- Price
- IVR $7.85
- MRVI $3.26
- Analyst Decision
- IVR Hold
- MRVI Hold
- Analyst Count
- IVR 2
- MRVI 9
- Target Price
- IVR $7.50
- MRVI $4.54
- AVG Volume (30 Days)
- IVR 1.4M
- MRVI 1.4M
- Earning Date
- IVR 10-30-2025
- MRVI 11-06-2025
- Dividend Yield
- IVR 17.30%
- MRVI N/A
- EPS Growth
- IVR N/A
- MRVI N/A
- EPS
- IVR 0.54
- MRVI N/A
- Revenue
- IVR $72,304,000.00
- MRVI $192,435,000.00
- Revenue This Year
- IVR $266.55
- MRVI N/A
- Revenue Next Year
- IVR $4.36
- MRVI $7.27
- P/E Ratio
- IVR $14.68
- MRVI N/A
- Revenue Growth
- IVR N/A
- MRVI N/A
- 52 Week Low
- IVR $5.86
- MRVI $1.67
- 52 Week High
- IVR $9.06
- MRVI $6.34
- Technical
- Relative Strength Index (RSI)
- IVR 64.37
- MRVI 56.14
- Support Level
- IVR $7.68
- MRVI $2.55
- Resistance Level
- IVR $7.56
- MRVI $2.95
- Average True Range (ATR)
- IVR 0.15
- MRVI 0.21
- MACD
- IVR 0.06
- MRVI -0.03
- Stochastic Oscillator
- IVR 97.24
- MRVI 71.00
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.